Security key
68232V884
Traws Pharma, Inc. - Common Stock, par value $0.01 per share (TRAW)
CUSIP: 68232V884
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock, par value $0.01 per share
- Total 13F shares
- 3,619,796
- Total 13F value
- $6,624,230
- Share change
- +201,203
- SEC-reported price per share
- $1.83
- Number of holders
- 27
- Value change
- +$459,630
- Number of buys
- 12
- Number of sells
- 11
- Shares outstanding
- 16,062,541
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
27
Top holders
10
TRAW full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Previous quarter: Q4 2025
Traws Pharma, Inc. SEC filings
Traws Pharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68232V884
Recent filing periods:
Ownership snapshot
Top reported holders of TRAW - Traws Pharma, Inc. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ikarian Capital, LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
Lead comparable stake: 10%
13D/G row: Ikarian Capital, LLC
Showing 1-6 of 15 holder rows.
Quick read
Ikarian Capital, LLC leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ikarian Capital, LLC's linked filing trail.
Comparable ownership
Top 5
Ikarian Capital, LLC
10%
Alyeska Investment Group, L.P.
9.9%
Adage Capital Management, L.P.
9.1%
Jorey Chernett
6.8%
Squadron Capital Management LLC
6.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ikarian Capital, LLC |
13D/G
13F
Company
|
10%
|
$1,308,164
812,524 shares
|
+$359,065 | 31 Dec 2025 |
| Alyeska Investment Group, L.P. |
13D/G
|
9.9%
|
$462,446
302,252 shares
|
$0 | 31 Dec 2024 |
| Adage Capital Management, L.P. |
13D/G
|
9.1%
|
$1,175,300
730,000 shares
|
+$644,000 | 31 Dec 2025 |
| Jorey Chernett |
13D/G
Chernett Jorey
|
6.8%
|
$668,220
543,268 shares
|
$0 | 14 Jan 2026 |
| Squadron Capital Management LLC |
13D/G
13F
Squadron Master Fund LP · Company
|
6.4%
|
$936,437
511,714 shares
|
-$369,342 | 31 Mar 2026 |
| PERCEPTIVE ADVISORS LLC |
13D/G
|
6.1%
|
$1,793,061
979,815 shares
|
+$170,058 | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
27
Shares
3,619,796
Rows available
27
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
21
Q1 2026 holders
27
Holder diff
6
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend